Total amount raised
$3.2 Million
Latest funding date
4/1/2024
Location
Medulance has successfully raised funding over two rounds, with the latest being a Series A round led by Alkemi Venture Partners. The company is backed by five investors, including Dexter Capital Advisors and Aman Gupta.
Keep reading to explore the intricacies of Medulance's fundraising journey and the investors backing this innovative platform.
What Is Medulance?
Medulance is a GPS-based technology platform designed to provide fast and reliable first point medical attention. The company is private and has raised funding through Series A rounds. It is based in New Delhi, India, and employs between 11 to 50 people.
Medulance operates within the GPS, medical, and mobile apps industries. Despite the obfuscation of the founding year and founder names, the company has made significant strides with investments from notable investors like Dexter Capital Advisors and Aman Gupta.
How Much Funding Has Medulance Raised?
- Seed Round
- Amount Raised: USD 240,000 (INR 20,000,000)
- Date: February 2023
- Lead Investors: Not publicly disclosed
- Valuation at Round: INR 100 crore
- Motivation Behind the Round: To support the company's growth and valuation.
- Series A Round
- Amount Raised: USD 3,000,000
- Date: April 2024
- Lead Investors: Alkemi Venture Partners
- Valuation at Round: Not publicly disclosed
- Motivation Behind the Round: To expand Medulance's reach across India, improve emergency management technology, and reduce emergency response times.
Total Amount Raised: USD 3,240,000. Current Valuation: Not publicly disclosed.
Key Investors
- Alkemi Growth Capital
- Details: Alkemi Growth Capital is a growth equity firm that invests in healthcare and consumer sectors. The firm led the $3 million Series A funding round for Medulance.
- Investment Focus Areas: Healthcare, life sciences, technology-driven healthcare solutions.
- Notable Investments: Not publicly disclosed.
- Dexter Capital
- Details: Dexter Capital is an investment firm known for its involvement in various startups and growth-stage companies. The firm participated in the Series A funding round for Medulance.
- Investment Focus Areas: Not publicly disclosed.
- Notable Investments: Not publicly disclosed.
- Aman Gupta
- Details: Aman Gupta is the co-founder of boAt, a consumer electronics brand. He participated in the Series A funding round for Medulance and previously invested in the company on Shark Tank India.
- Investment Focus Areas: Consumer electronics, startups, technology.
- Notable Investments: boAt.
- Namita Thapar
- Details: Namita Thapar is the Executive Director of Emcure Pharmaceuticals. She participated in the Series A funding round for Medulance and previously invested in the company on Shark Tank India.
- Investment Focus Areas: Pharmaceuticals, healthcare, startups.
- Notable Investments: Not publicly disclosed.
What's Next for Medulance?
Medulance is poised for significant growth, with plans to expand its emergency healthcare services to over 1,000 cities in India within the next 15 to 18 months. Leveraging 5G technology and smart remote monitoring, the company aims to create a comprehensive emergency healthcare ecosystem. This expansion presents a substantial opportunity to impact a large population, particularly in tier-2 and tier-3 cities, where access to quality emergency services is often limited.
To support this ambitious growth, Medulance may seek additional funding rounds. The company’s focus on technological advancements and public-private partnerships could attract further investments from both private and public sectors. These funds would be crucial for scaling operations, enhancing emergency management technology, and recruiting qualified medical professionals through initiatives like the Medulance Healthcare Academy.
However, Medulance faces several challenges, including maintaining consistent service quality across diverse regions and integrating advanced technologies into existing infrastructure. Navigating regulatory complexities and forming effective public-private partnerships will also be critical. Despite these hurdles, the company’s strategic approach and robust growth plans position it well for future success in the rapidly evolving healthcare sector.
Use Clay to Get Funding Data
Sales professionals, leverage Clay’s platform to access comprehensive fundraising data on companies like Medulance and gather other critical business insights. Sign up for free to start transforming your sales strategy today.
